Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2025-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$37.1m
reported value
-36.5% vs Q4 2024
12positions
93.8%in top 10
1 new
3 added
7 reduced
2 sold out
vs Q4 2024
Options: 1 call positions ($18.7m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q1 2025
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BLUEPRINT MEDICINES CORP BPMC | $7.4m20.03% | Reduced -45.7k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $7.0m18.90% | Reduced -157.5k |
| PROTAGONIST THERAPEUTICS INC PTGX | $4.0m10.65% | Added +5.1k |
| KYMERA THERAPEUTICS INC KYMR | $3.8m10.22% | Reduced -45.0k |
| PRECISION BIOSCIENCES INC DTIL | $3.5m9.34% | Added +189.8k |
| ARVINAS INC ARVN | $2.5m6.83% | Added +32.0k |
| REGENXBIO INC RGNX | $1.9m5.23% | Reduced -75.0k |
| ADICET BIO INC COM | $1.9m5.00% | Reduced -75.0k |
| BICYCLE THERAPEUTICS PLC BCYC | $1.5m3.93% | Reduced -50.2k |
| IMMATICS N.V IMTX | $1.4m3.71% | Reduced -69.0k |
| REPARE THERAPEUTICS INC RPTX | $1.3m3.44% | Unchanged |
| ZYMEWORKS INC ZYME | $1.0m2.71% | New |
Sold out since Q4 2024
| Security | Value then |
|---|---|
| SILENCE THERAPEUTICS PLC SLN | $2.5m367.2k shares |
| SUTRO BIOPHARMA INC | $916498 shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| AMGEN INC AMGN · Call | $18.7m60.0k shares | Added |